Interaction analysis also revealed that the combined effect of YAP and AR significantly amplified the risk of disease progression, providing a theoretical basis for dual-targeted therapy against YAP and AR.[3,17] In future therapeutic strategies, simultaneous inhibition of the YAP and AR signaling pathways may represent a promising direction for osteosarcoma treatment. Here, AR is linked to osteosarcoma.